Jade Biosciences Inc.
JBIO | NASDAQ
$13.70
-$0.36 (-2.56%)
Nov 2, 2026, 12:10 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 18K | 9K | 4K | 12K | 12K | 40K | 64K | 84K | 109K | 81K | 53K | 25K |
Gross Profit | -18K | -9K | -4K | -12K | -12K | -40K | -64K | -84K | -109K | -81K | -53K | -25K |
Operating Income | -164.74M | -133.6M | -93.55M | -64.97M | -52.53M | -50.92M | -72.15M | -87.81M | -94.22M | -68.05M | -43.43M | -21.37M |
Interest Income | 11.67M | 10.27M | 8.04M | 5.98M | 4.12M | 3.68M | 4.25M | 4.93M | 6.34M | 4.95M | 3.51M | 1.8M |
Pretax Income | -153.15M | -129.54M | -91.7M | -65.2M | -56.3M | -48.95M | -69.61M | -84.6M | -87.88M | -63.11M | -39.92M | -19.56M |
Net Income | -153.24M | -129.61M | -91.76M | -65.26M | -56.36M | -49M | -69.67M | -84.65M | -87.94M | -63.16M | -39.98M | -19.56M |
Selling & General & Admin | 28.05M | 24.44M | 20.44M | 18.87M | 14.86M | 14.52M | 15.65M | 15.01M | 18.08M | 13.19M | 8.68M | 4.46M |
Research & Development | 136.67M | 109.15M | 73.1M | 46.09M | 37.66M | 36.36M | 56.44M | 72.72M | 76.03M | 54.78M | 34.7M | 16.88M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 164.72M | 133.59M | 93.54M | 64.96M | 52.52M | 50.88M | 72.09M | 87.73M | 94.11M | 67.97M | 43.38M | 21.34M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 100K | 100K | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 164.74M | 133.6M | 93.55M | 64.97M | 52.53M | 50.92M | 72.15M | 87.81M | 94.22M | 68.05M | 43.43M | 21.37M |
Income Tax Expense | 89K | 74K | 58K | 55K | 55K | 55K | 55K | 56K | 56K | 56K | 56K | n/a |
Shares Outstanding (Basic) | 61.05M | 57.78M | 49.32M | 39.58M | 28.43M | 828.14K | 828.14K | 3.16M | 821.6K | 794.17K | 791.29K | 789.73K |
Shares Outstanding (Diluted) | 61.05M | 57.78M | 49.32M | 39.58M | 28.43M | 828.14K | 828.14K | 3.16M | 821.6K | 794.17K | 791.29K | 789.73K |
EPS (Basic) | -2.75 | -3.12 | -5.46 | -11.37 | -15.89 | -44.91 | -71.06 | -90.31 | -109.92 | -79.76 | -50.57 | -24.77 |
EPS (Diluted) | -2.75 | -3.12 | -5.46 | -11.37 | -15.89 | -44.91 | -71.06 | -90.31 | -109.92 | -79.76 | -50.57 | -24.77 |
EBITDA | -156.28M | -129.5M | -91.68M | -65.18M | -56.29M | -48.91M | -69.55M | -84.51M | -87.77M | -63.03M | -39.87M | -19.54M |
EBIT | -156.32M | -129.54M | -91.7M | -65.2M | -56.3M | -48.95M | -69.61M | -84.6M | -87.88M | -63.11M | -39.92M | -19.56M |
Depreciation & Amortization | 39K | 31K | 26K | 25K | 13K | 40K | 64K | 84K | 109K | 81K | 53K | 25K |
Add to Watchlist
Select watchlists to add or remove JBIO